IWS
IHE icon

Insight Wealth Strategies’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Insight Wealth Strategies’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Buy
122,642
+3,950
+3% +$356K 1.18% 25
2026
Q1 		$10.3M Buy
+118,692
New +$10.4M 1.15% 26

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Insight Wealth Strategies's IHE Position: Q2 2026 in Review

Insight Wealth Strategies increased its iShares US Pharmaceuticals ETF (IHE) stake by 3.3% in Q2 2026, buying an estimated $356K and bringing the position to 122,642 shares worth $12.1M. The position accounts for 1.18% of the portfolio, ranked #25.

Insight Wealth Strategies first reported a position in IHE in Q1 2026 and has held it in 2 quarters since. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Insight Wealth Strategies held 122,642 shares of iShares US Pharmaceuticals ETF worth $12.1M as of Q2 2026.
  • Insight Wealth Strategies bought 3,950 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $356K.
  • iShares US Pharmaceuticals ETF made up 1.18% of Insight Wealth Strategies's portfolio in Q2 2026, its #25 holding.
  • Insight Wealth Strategies first reported a position in iShares US Pharmaceuticals ETF in Q1 2026 and has held it in 2 quarters since.
  • 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Insight Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.